Either way, the strength of our work is validated by the fact that we could observe elevation in previously reported cancer-specific biomarkers in specific cancers, such as G-CSF, GM-CSF, IL-10, and PECAM-1 (seeTable 1 for HC to cancer differences) [24]. The gene discussed is CSF2; the disease is cancer.